PharmaCan Capital Corp. — Form D
PharmaCan Capital Corp. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2015-10-23. The offering totals $4.0M, of which $1.1M was reported sold. Industry: Investing.
Offering
- Filed: 2015-10-23
- Form: D
- Accession: 0001656472-15-000001
- Industry: Investing
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.1M
- Remaining: $2.8M
- Investors: 6
- Date of first sale: 2015-10-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-249981
Issuer
- Name: PharmaCan Capital Corp.
- CIK: 0001656472
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2012
- Address: 76 STAFFORD STREET, SUITE 302, TORONTO, A6, M6J 2S1
- Phone: (416) 504-0004
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Lorne Gertner | Director | Chicago, IL |
| Glen Huber | Director | Toronto, A6 |
| Steven Howard Isenberg | Director | Toronto, A6 |
| Ryan Roebuck | Director | Vancouver, A1 |
| Paul Rosen | Director | TORONTO, A6 |
| Paul Rosen | Executive Officer | TORONTO, A6 |
| Alan Friedman | Director | TORONTO, A6 |
| Michael Gorenstein | Director | Toronto, A6 |
| Michael Gorenstein | Executive Officer | Toronto, A6 |
| Glen Huber | Executive Officer | Toronto, A6 |
| Michael Howard Krestell | Director | Toronto, A6 |
Other filings by this issuer (1)
More